Advocacy group seeks ban on pelvic surgical mesh

(AP) -- A consumer advocacy group is calling on government regulators to ban a type of surgical mesh used to treat pelvic collapse, saying it exposes patients to serious risks.

Public Citizen sent a petition to the asking the agency to ban pelvic surgical mesh inserted through the vagina. About 75,000 women had prolapse surgery with forms of the mesh last year, according to the FDA.

FDA announced last month that complications with mesh are higher than previously estimated, with many women experiencing pain, bleeding and infection. Public Citizen said mesh offers no benefit over traditional surgery with stitches.

"Even the FDA seriously questions the safety and effectiveness of these mesh products, so they should be removed from the market immediately," said Public Citizen's Dr. Michael Carome.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

FDA: pelvic mesh for women riskier than thought

Jul 13, 2011

A product commonly used in surgery to treat incontinence and other women's health problems causes far more complications than previously thought and is likely exposing patients to unnecessary risks, according to U.S. health ...

Researchers offer hope to prolapse sufferers

May 17, 2011

Scientists in Scandinavia have found a new way to treat sufferers of pelvic organ prolapse. Presented in the New England Journal of Medicine, their study reveals that the use of synthetic mesh can have a more ...

Synthetic mesh can improve outcome of prolapse surgery

May 12, 2011

(Medical Xpress) -- A Nordic multicentre study, headed by researchers from Karolinska Institutet, shows that pelvic organ prolapse surgery using synthetic mesh can be more effective than traditional surgery. The advantages ...

Watchdog group makes 2nd push to ban diet pill

Apr 18, 2011

(AP) -- For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments